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ABSTRACT
Background and Objectives: We report our institutional
experience performing transperitoneal robotic-assisted
laparoscopic prostatectomy (RALP) in patients with prior
prosthetic mesh herniorrhaphy to assess the feasibility of
this procedure in this patient population.
Methods: From October 2005 to January 2008, transperi-
toneal robotic-assisted laparoscopic prostatectomies were
performed and prospectively recorded. We retrospec-
tively reviewed 309 patients.
Results: Twenty-seven patients (8.7%) were found to
have a history of prior hernia repair with prosthetic mesh
placement. The mean age was 55.7, estimated blood loss
(EBL) was 228 mL, operative (console) time was 197
minutes, and length of hospital stay (LOS) was 1.62 days.
In contrast, patients undergoing RALP with no history of
mesh herniorrhaphy had a mean age of 59.3, EBL of 302
mL, console time of 193 minutes, and LOS of 2.2 days.
These differences were not statistically significant. The
mesh herniorrhaphy cohort had a lower percentage of
organ-confined disease, but no difference was seen in
margin status, continence, or potency rates after one year.
Conclusions: Transperitoneal RALP is a feasible option
for previously operated on patients with prosthetic mesh
herniorrhaphy. Two areas that we identified as critical
were the initial step of gaining access for pneumoperito-
neum and port placement, and meticulous dissection to
expose the mesh, which can be subsequently avoided and
left intact. As RALP continues to gain popularity, urologists
will continue to exploit the advantages of robotic surgery
to perform increasingly challenging cases.
Key Words: Prostatectomy, Hernia repair, Mesh, Laparos-
copy, Robotics.
INTRODUCTION
Robotic-assisted laparoscopic prostatectomy (RALP) has
gained increasing popularity and acceptance in urologic
practice. Compared with laparoscopic prostatectomy
(LRP), the advantages of improved visualization, ergo-
nomics, and instrumental range of motion have dramati-
cally decreased the learning curve to achieve profi-
ciency.1–3 In addition, emerging studies demonstrate
similar clinical and pathological outcomes compared with
traditional radical retropubic prostatectomy (RRP).4,5
Inguinal hernia repair with the incorporation of prosthetic
mesh has been reported to create a dense, fibrotic reac-
tion, complicating future pelvic procedures.6 There have
been several reports of surgeons encountering severe fi-
brosis and scarring during RRP in patients who have
undergone prior mesh hernia repairs, leading to early
termination of the procedure.7–9 In addition, prosthetic
mesh used in umbilical hernia repairs can similarly cause
intraperitoneal adhesions and scarring, making port place-
ment and dissection technically challenging in patients
who undergo intraperitoneal laparoscopic or robotic pro-
cedures. This dense inflammation and fibrosis can destroy
natural planes of dissection and compromise oncological
surgery.6 Due to these issues, prior laparoscopic hernior-
rhaphy with mesh has been considered a relative contra-
indication to RRP and LRP.
Recent studies have reported that LRP after prior laparo-
scopic inguinal herniorrhaphy is feasible and does not
adversely affect operative and functional results.10,11 We
retrospectively reviewed our institutional experience with
RALP concerning patients who had undergone prior her-
niorrhaphy with prosthetic mesh to assess the feasibility of
robotic prostatectomy in this patient population.
METHODS
From the initiation of RALP at Thomas Jefferson University
Hospital in October 2005 until January 2008, 309 proce-
dures were performed by 2 surgeons (CDL and EJT) and
were recorded in our robotic database. After obtaining
approval from our institutional IRB, demographic and
perioperative data were collected prospectively. In addi-
tion, data regarding final pathology, extracapsular exten-
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SCIENTIFIC PAPERsion, and margin status were documented. The 4-armed
da Vinci robot (Intuitive Surgical, Inc., Sunnyvale, CA) was
used for all cases, and all were performed intraperitone-
ally, using a 6-port setup. Statistical analysis was per-
formed on all data by using the chi-square test to compare
patients with and without a history of mesh hernior-
rhaphy.
RESULTS
The records of these 309 patients were reviewed. Patient
characteristics and perioperative data are shown in Table
1. A total of 27 patients (8.7%) were identified as having
prior herniorrhaphy with prosthetic mesh placement. For
the series, the mean age was 55.7. The mean estimated
blood loss was 227.7 mL, console time was 197 minutes,
and length of stay was 1.62 days. Postoperative anemia
requiring transfusion in one patient was the only compli-
cation seen in the group. By contrast, our patients with no
history of hernia repair who underwent RALP had a mean
age of 59.3, mean EBL of 301.8 mL, console time of 187
minutes, and length of stay of 2.16 days; however, these
differences were not statistically significant (Table 1).
Perioperative pathologic parameters are demonstrated in
Table 2. Of note, a significant difference was seen in the
final pathologic stage, with a much larger number of those
patients without mesh herniorrhaphy being pT2
(P0.001). Regardless, positive margin rates for both pT2
and pT3/4 disease were similar for both cohorts. PSA data
need to mature.
Quality of life outcomes for both cohorts of patients are
demonstrated in Table 3. In accordance with the lower
amount of organ-confined disease, fewer nerve-sparing
procedures were performed in the mesh herniorrhaphy
patients. This did not translate into a significant difference
in either postoperative continence or potency, when strat-
ified for nerve-sparing results. This table shows follow-up
at 1 year and includes both mean International Index of
Erectile Function (IIEF) and International Prostate Symp-
tom Score (IPSS) results for both groups of patients. Con-
tinence was defined as 1 pad per day for protection, and
potency as successful vaginal penetration with or without
the use of pharmacotherapy.
DISCUSSION
Laparoscopic prostatectomy was first reported in 1997.12
The advantages of increased visual acuity and decreased
patient morbidity and convalescence were evident; how-
ever, the procedure was technically demanding and was
associated with a steep learning curve. The introduction of
the da Vinci robot to assist in laparoscopic prostatectomy
has significantly reduced the learning curve, making the
procedure technically feasible.2 As RALP has gained in-
creasing acceptance, recent data are emerging that show
outcomes comparable to those of RRP.4,5
Laparoscopic umbilical and inguinal hernia repair have
become increasingly popular.13 Although the number of
laparoscopic hernia repairs is rising, the incorporation of
prosthetic mesh may interfere with future surgical proce-
dures. Laparoscopic inguinal hernia repair, in particular,
has been associated with extensive intraabdominal and
pelvic fibrosis and inflammation, making radical retropu-
bic prostatectomy so difficult that early termination of the
procedure has been reported.6–8Katz et al9 reported on 2
patients with prior laparoscopic bilateral inguinal hernia
repairs who underwent RRP. In each case, considerable
inflammation and scarring was encountered. In one case,
the mesh completely obliterated the space of Retzius, and
further dissection could not be safely performed. The
procedure was subsequently aborted and the patient un-
derwent external beam radiotherapy. The second case
was completed, albeit with great difficulty. The authors
concluded that RRP after laparoscopic inguinal hernia
Table 1.
Mean Age, Estimated Blood Loss, Console Time, and Length of Stay of Robotic-Assisted Laparoscopic Prostatectomy (RALP)
Patients, With and Without Prior Mesh Herniorraphy
RALP With History of
Mesh Herniorrhaphy
RALP Without Mesh
Herniorrhaphy
P Value
Number of Patients 27 (8.7%) 282 (91.3%)
Age (years), mean 55.7 59.3 P  0.67
Estimated Blood Loss (mL), mean 227.7 301.8 P  0.61
Console Time (min), mean 197 187 P  0.45
Length of Stay (days), mean 1.62 2.16 P  0.51
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that patients should be counseled with appropriate alter-
native treatment options.
Since the publication of that case report, other authors7,8
have described similar experiences. There is general con-
sensus amongst these reports that the inflammatory reac-
tion surrounding the anterior bladder may compromise an
already tenuous vesicourethral anastomosis and that care-
ful and meticulous nerve-sparing is not assured.8,9 One
group reported that the oncological outcomes of future
pelvic surgery may be compromised as well.6 They de-
scribed a patient with muscle-invasive bladder cancer
who had undergone prior bilateral laparoscopic hernia
repair and was scheduled for a radical cystoprostatec-
tomy. Intraoperative difficulties with dissection due to the
mesh concerned the authors that such conditions could
lead to bladder perforation and tumor spillage, adversely
affecting the clinical outcome and overall patient prog-
nosis.
With regard to minimally invasive prostatectomy, Erdogru
et al11 reported their experience with LRP after prior open
or laparoscopic inguinal hernia repair. In their series of
over 1000 patients who underwent LRP, 20 were identified
with a history of prior laparoscopic inguinal hernia repair.
This cohort was matched and compared with a group of
LRP patients with a history of open hernia repair and a
group of LRP patients with no history of herniorrhaphy.
They found no differences in mean operative time, EBL,
positive margin rate and continence. The authors found
that prior open and laparoscopic herniorrhaphy did not
present any noteworthy disadvantage during the proce-
dure and concluded that LRP can be performed safely in
these patients.
Table 2.
Preoperative and Postoperative Pathologic Comparison of Patients With and Without Mesh Herniorrhaphy
*RALP With History of
Mesh Herniorrhaphy
RALP Without Mesh
Herniorrhaphy
P Value
Number of patients 27 (8.7%) 282 (91.3%)
Preoperative PSA 6.4 6.2 0.52
Preoperative clinical stage T1c 74.1% 77.0% 0.74
Pathologic T2 51.9% 82.1% 0.001
Total positive margin 18.5% 15.6% 0.17
Positive margin pT2 7.1% 11.1% 0.57
Positive margin pT3/4 30.8% 34.2% 0.79
*RALProbotic-assisted laparoscopic prostatectomy.
Table 3.
Functional Outcomes of Patients With and Without Mesh Herniorrhaphy. One-year Follow-up Demonstrated
RALP With History of
Mesh Herniorrhaphy
RALP Without Mesh
Herniorrhaphy
P Value
Number of Patients 27 (8.7%) 282 (91.3%)
Continent (Mean Baseline/Followup IPSS*) 89% (9.4/8.4) 91% (8.6/5.7) 0.75
Bilateral Nerve Spare 44% 60% 0.13
Potent (Mean baseline/followup IIEF*) 83% (59/34) 81% (55/39) 0.84
Unilateral nerve spare 7.4% 14.1% 0.86
Potent (Mean baseline/followup IIEF*) 50% (31/26) 26.7% (44/16) 0.27
Non nerve spare 48.1% 26.3% 0.14
Potent (Mean baseline/followup IIEF*) 7.7% (42/8) 9.0% (37/3) 0.72
*IPSSInternational Prostate Symptom score. IIEFInternational Index of Erectile Function.
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in patients with prior laparoscopic herniorrhaphy. Brown
and Dahl10 reported the first cases of performing LRP to
completion in patients with previous laparoscopic ingui-
nal hernia repair. They acknowledged that dense scarring
may be present, but with the aid of laparoscopy, optimal
planes of dissection can be better visualized, and the
anterior bladder may be freed from mesh under direct
visualization. In addition, there would be no compromise
to the hernia repair, and the exposure of the mesh could
be avoided. In the current series, 2/27 (7.4%) of our
patients with a history of prior mesh hernia repair had
undergone a bilateral laparoscopic inguinal hernia repair.
Only 4 patients in all had undergone a laparoscopic her-
niorrhaphy; in addition to these, one patient underwent a
unilateral inguinal hernia repair and one an umbilical
hernia repair with mesh. In all of these patients, the RALP
was completed without complication.
Although not reported, laparoscopic umbilical hernia re-
pair can pose a similar surgical dilemma regarding a fi-
brotic inflammatory response associated with the mesh
and the surrounding adhesions that form. This can be
particularly problematic for pelvic laparoscopic proce-
dures that are initiated intraperitoneally, such as the trans-
peritoneal RALP. Accordingly, this may be obviated
through extraperitoneal RALP. Extraperitoneal RALP has
been reported to have no significant difference in opera-
tive time, EBL, length of stay, or complication rate com-
pared with the transperitoneal approach.14–16 In addition,
patients with prior lower abdominal or pelvic surgery
undergoing extraperitoneal RALP have similar operative
characteristics and complication rates compared with pa-
tients with no prior surgery.17 In particular, concerning
patients with a prior history of prosthetic mesh inguinal
herniorrhaphy, Stolzenburg et al18 reported that simple
modifications in port placement and surgical technique
have made laparoscopic extraperitoneal prostatectomy a
possibility. However, although the extraperitoneal ap-
proach may be a promising alternative for this patient
population, creating the extraperitoneal space in a patient
with mesh can be equally daunting as we have seen in the
RRP literature.7–9
To our knowledge, there is one other series in the litera-
ture describing transperitoneal robotic-assisted laparo-
scopic prostatectomy in patients with prior intraabdomi-
nal mesh.19 These investigators determined that RALP is
feasible in patients with a history of hernia repair both
with and without mesh, but only a minority (3%) of their
patients had a history of mesh herniorrhaphy. In our
institutional experience of 309 transperitoneal robotic
prostatectomies, almost 9% of the patients had undergone
prior mesh hernia repair. Interestingly, in our retrospec-
tive comparison, patients with a history of mesh hernior-
rhaphy had a slightly longer operative time but a lower
EBL and shorter LOS. Although these differences did not
attain statistical significance, we attributed these results to
patient selection. We attempted more challenging cases
later in our experience, and thus were able to demonstrate
outcomes that were at least equivalent, and actually trend-
ing toward improvement. Although fewer of our mesh
herniorrhaphy patients had organ-confined disease, nei-
ther pathologic nor quality of life outcomes appeared to
suffer despite the more difficult dissection, again more
likely a result of being higher on the learning curve when
those cases were undertaken (Tables 2 and 3). This was
even the case in patients who had a laparoscopic inguinal
hernia repair, who theoretically could have a tenuous
anastomosis from scarring at the anterior bladder; these
patients were not affected with regard to their continence.
Pelvic lymph node dissection (PLND) was performed in
patients stratified preoperatively to intermediate and high-
risk disease. Early in our series, patients defined as low-
risk using the D’Amico classification did not undergo
pelvic lymphadenectomy.20 Later in our series, PLND was
not performed in patients whose predicted risk of nodal
involvement was 1% or less based on the Kattan preop-
erative nomogram.21 However, over the last 15 months,
we have performed PLND in all patients undergoing
RALP, regardless of risk, because of the diagnostic value
and low risk of the procedure. According to these criteria,
the majority of our patients (19/23) with inguinal mesh
underwent pelvic lymph node dissection. There was no
increase in difficulty noted during the dissection in these
patients; no significant difference in intraoperative char-
acteristics was seen compared with that in patients who
did not undergo pelvic lymph node dissection.
In a patient with a prior history of herniorrhaphy with
prosthetic mesh placement, it is essential to proceed with
caution, given the variable number of adhesions and fi-
brosis that may be encountered. Of paramount impor-
tance is gaining optimal access with precise port place-
ment. Access into the abdomen must be carefully planned
and executed. If patients have a prior history of umbilical
hernia repair, we recommend gaining access remote from
the area of the mesh, such as in the right upper quadrant,
where the likelihood of encountering adhesions is less
likely. In addition, although we did not in our experience,
one could consider the Hassan technique of laparoscopic
access. Once optimal port placement is obtained, the
exceptional visualization supplied by the robotic system
JSLS (2009)13:142–147 145and a laparoscopic template can facilitate meticulous dis-
section through a scar created by previously placed mesh.
The intercalated mesh can be visualized and avoided,
leaving the hernia repair intact (Figure 1).
CONCLUSIONS
Hernia repair with intraabdominal mesh has been re-
ported to complicate and potentially compromise onco-
logical procedures, particularly RRP. We have shown
through our institutional experience that RALP, in patients
with a prior history of herniorrhaphy with mesh place-
ment, is a reasonable alternative to LRP or RRP. We be-
lieve that with the growing popularity of RALP, urologists
will continue to expand their indications for the proce-
dure, exploiting the known advantages of robotic surgery
to undertake more challenging cases, including patients
with mesh herniorrhaphy.
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